Menstrual Cycle Symptom Tracking

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

104 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-22

Study Completion Date

2021-09-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will provide menstrual cycle symptom information from women over the course of three menstrual cycles to determine whether there are any noticeable physiological changes that can be related to stage of the menstrual cycle or onset of menstruation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clearblue® Advanced Ovulation Test User Study

NCT03122951

Trying to Conceive Population

COMPLETED NA

The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology

NCT05683119

Menstrual Cycle Oral Contraceptives

RECRUITING NA

Period Tracker Lay User Study

NCT05091658

Menstrual Cycles

COMPLETED

Performance During Menstrual Cycle

NCT03832972

Performance

COMPLETED

Sensor Technology Assessments of Reproductive Target Study

NCT06142097

Menstrual Cycle Ovulation Menstruation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menstrual Cycles

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clearblue Connected Ovulation Test System

Clearblue Connected Ovulation Test System which is a CE marked device used for tracking the menstrual cycle

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female
* Aged 18 years and over
* Regular menstrual cycles
* Owns a compatible smart phone i.e. iPhones® and AndroidTM phones equipped with Bluetooth® 4.0/BLE
* Willing to use their own smartphone for the duration of this study and to download and install the study app
* Willing to give informed consent

Exclusion Criteria

* Currently trying to conceive
* Currently or recently pregnant or breastfeeding
* Taking any treatment which may affect the menstrual cycle (e.g. contraceptive pill, fertility medications or hormone replacement therapy)
* Taking or undergoing any other medical treatment for fertility such as ovulation drugs, artificial insemination and assisted fertility such as In vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI)
* Has abnormal liver or kidney function
* Taking antibiotics containing tetracycline
* Taking clomiphene citrate or other ovulation induction drugs

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes